Barbara Natke

Chief Business Officer @The Progeria Research Foundation

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Chief Business Officer @The Progeria Research Foundation

View department →

Peabody, MA, US

Business Development: Identifying and cultivating business partners to work with us to find a cure for Progeria, an ultra-rare disease.Portfolio Management: Creating the overall PRF business strategy to prioritize all therapeutic options and identify the best path forward.Translational Science: Supporting clinical development of potentially transformative therapies for Progeria through biomarker validation.

EDUCATION

1985 — 1989

Loyola University Chicago

B.S., Biology

2017 — 2019

Babson F.W. Olin Graduate School of Business

Master of Business Administration - MBA, Magna cum laude

1989 — 1997

Boston University School of Medicine

PhD, Biochemistry

ABOUT BARBARA NATKE

An experienced Business Development executive utilizing a strong scientific background to create risk-adjusted portfolios through in- and out-licensing, deep-dive diligence and creative deal structuring. Over twenty years of Biotech/Pharma experience with an extensive knowledge of the entire drug development process from discovery through NDA submission, post-marketing requirements and commercialization. Adept at communicating complex scientific concepts to new audiences to facilitate and expedite partnering discussions.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Barbara Natke — Chief Business Officer at The Progeria Research Foundation in Boston, MA, US | Unifers